These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2906261)
1. Long term H2 antagonists in peptic ulcer disease. Cooper GJ; Kerrigan DD; Johnson AG BMJ; 1988 Dec; 297(6663):1612. PubMed ID: 2906261 [No Abstract] [Full Text] [Related]
2. Comparison of different strategies for treatment of duodenal ulcer. Sonnenberg A Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1185-7. PubMed ID: 2859078 [TBL] [Abstract][Full Text] [Related]
3. [Supraselective vagotomy. Long-term results in the treatment of duodenal ulcer]. de Mestier P; Vallot T Presse Med; 1992 Jun; 21(22):1014-6. PubMed ID: 1354868 [No Abstract] [Full Text] [Related]
4. The role of surgery in the modern treatment of peptic ulcer disease. Speranza V; Lezoche E; Carlei F Ital J Surg Sci; 1984; 14(4):345-9. PubMed ID: 6152451 [No Abstract] [Full Text] [Related]
9. Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy? Primrose JN; Naik KS; Blackett RL; King RF; Holmfield JH; Lagopolous M; Johnston D Gut; 1990 Jul; 31(7):763-6. PubMed ID: 1973394 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of resistant duodenal ulcer]. Vigneri S; Scialabba A; Pisciotta G; Termini R; Muratore F; Vinti M Minerva Med; 1989 Nov; 80(11):1205-10. PubMed ID: 2574838 [TBL] [Abstract][Full Text] [Related]
11. Vagotomy for duodenal ulcer resistant to H2-receptor antagonists. Vassilakis JS; Xynos E; Mantidis A; Zoras OJ; Nikolopoulos N Digestion; 1989; 44(1):1-6. PubMed ID: 2574693 [TBL] [Abstract][Full Text] [Related]
12. Today's treatment of chronic duodenal ulcer. H2 antagonists and the role of surgery. Clark CG Practitioner; 1983 Apr; 227(1378):543-6. PubMed ID: 6134276 [No Abstract] [Full Text] [Related]
13. Effect of H2 antagonists on outcome of simple closure for perforated duodenal ulcer. Koh KB; Chang KW Singapore Med J; 1992 Oct; 33(5):472-3. PubMed ID: 1360708 [TBL] [Abstract][Full Text] [Related]
14. [Peptic ulcer: changes in the surgical approach after the introduction of H2-antagonists in clinical practice]. Rimassa PL; Marino G; Quartapelle V; D'Asta F; Maggiolo G; Manno A; Piffero D; Schiappacasse E Minerva Chir; 1987 Oct; 42(19):1499-502. PubMed ID: 2891087 [No Abstract] [Full Text] [Related]
15. Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists. Primrose JN; Axon AT; Johnston D Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1031-5. PubMed ID: 3130125 [TBL] [Abstract][Full Text] [Related]
17. Costs of medical and surgical treatment of duodenal ulcer. Sonnenberg A Gastroenterology; 1989 Jun; 96(6):1445-52. PubMed ID: 2565844 [TBL] [Abstract][Full Text] [Related]
18. [Influence of H2-blocking drugs on the surgical therapy of peptic ulcer]. Procacciante F; Pronio A; Perri S; Di Nardo A; Montesani C; Citone G; Catani M; Ribotta G Minerva Chir; 1987 Oct; 42(19):1491-4. PubMed ID: 2891085 [No Abstract] [Full Text] [Related]